Research location
Clifton
New Jersey, United States
Advertisement
Research activity in Clifton
New Jersey, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 46 trials and 47 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Clifton
46 linked trials · page 1 of 1Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialNCT06496256 · 2024-10-31 · 1 site observation
RECRUITING
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)NCT05288166 · 2022-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.NCT05059236 · 2021-11-04 · 1 site observation
COMPLETED
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerNCT04975308 · 2021-10-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the ProstateNCT04136353 · 2020-03-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis RemissionNCT02373813 · 2015-02-20 · 1 site observation
COMPLETED
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid ArthritisNCT02137226 · 2015-01-26 · 1 site observation
COMPLETED
A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX AloneNCT02066389 · 2014-03-26 · 1 site observation
COMPLETED
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisNCT02092467 · 2014-03-14 · 1 site observation
COMPLETED
An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid ArthritisNCT02049138 · 2014-01-24 · 1 site observation
COMPLETED
Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)NCT01894516 · 2013-10-08 · 1 site observation
COMPLETED
Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid ArthritisNCT01999192 · 2013-10-01 · 1 site observation
TERMINATED
Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With AdalimumabNCT01752855 · 2012-12-01 · 1 site observation
COMPLETED
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid ArthritisNCT01682512 · 2012-09-05 · 1 site observation
TERMINATED
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa BiologicsNCT01636817 · 2012-08-01 · 1 site observation
TERMINATED
A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)NCT01662063 · 2012-08-01 · 1 site observation
COMPLETED
A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and SafetyNCT01712178 · 2012-06-01 · 1 site observation
COMPLETED
24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking MethotrexateNCT01590459 · 2012-04-01 · 1 site observation
COMPLETED
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisNCT01519791 · 2012-01-01 · 1 site observation
COMPLETED
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisNCT01521923 · 2012-01-01 · 1 site observation
COMPLETED
Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes MellitusNCT01451398 · 2011-11-01 · 1 site observation
COMPLETED
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)NCT01443845 · 2011-09-30 · 1 site observation
COMPLETED
An Open Label Study for Participants With Rheumatoid ArthritisNCT01215942 · 2011-06-01 · 1 site observation
TERMINATED
Antihypertensive Treatment of Acute Cerebral Hemorrhage-IINCT01176565 · 2011-05-15 · 1 site observation
TERMINATED
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-InhibitorNCT01283971 · 2011-05-01 · 1 site observation
TERMINATED
A Study in Participants With Rheumatoid ArthritisNCT01202773 · 2011-01-01 · 1 site observation
TERMINATED
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation
COMPLETED
A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis SubjectsNCT01255761 · 2010-11-01 · 1 site observation
COMPLETED
Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)NCT01185301 · 2010-10-01 · 1 site observation
COMPLETED
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid ArthritisNCT01194414 · 2010-09-01 · 1 site observation
COMPLETED
A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)NCT01185288 · 2010-09-01 · 1 site observation
COMPLETED
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisNCT01007435 · 2009-10-31 · 1 site observation
COMPLETED
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)NCT00891020 · 2009-05-01 · 1 site observation
COMPLETED
Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusNCT00789750 · 2009-04-01 · 1 site observation
COMPLETED
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin MonotherapyNCT00823992 · 2009-01-01 · 1 site observation
COMPLETED
Welchol as Monotherapy for Type 2 Diabetes MellitusNCT00789737 · 2009-01-01 · 1 site observation
COMPLETED
OVATIO CRT and SITUS OTW LV Lead Post Approval StudyNCT00795873 · 2008-12-01 · 1 site observation
COMPLETED
A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or ThiazolidinedioneNCT00743002 · 2008-08-01 · 1 site observation
COMPLETED
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.NCT00603382 · 2007-12-01 · 1 site observation
COMPLETED
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.NCT00603746 · 2007-12-01 · 1 site observation
COMPLETED
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid ArthritisNCT00535782 · 2007-10-31 · 1 site observation
COMPLETED
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-NaiveNCT00495469 · 2007-08-17 · 1 site observation
COMPLETED
Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High CholesterolNCT00701883 · 2007-08-01 · 1 site observation
COMPLETED
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra RiskNCT00412113 · 2007-01-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 2 site observations
COMPLETED
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT00106574 · 2005-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.